Results of nurse navigator follow-up after positive colorectal cancer screening test: A randomized trial

Journal of the American Board of Family Medicine

Volumn 27, Issue 6, 2014, Pages 789-795

  Green, Beverly B ^a   Anderson, Melissa L ^a   Wang, Ching Yun ^c   Vernon, Sally W ^d   Chubak, Jessica ^a,b   Meenan, Richard T ^e   Fuller, Sharon ^a  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^e CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

Cancer screening; Colonoscopy; Colorectal cancer; Patient navigators

Indexed keywords

ADULT; AGED; ARTICLE; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PATIENT CARE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; REGISTERED NURSE; SELF CARE; SIGMOIDOSCOPY; COLORECTAL NEOPLASMS; MASS SCREENING; MIDDLE AGED; UTILIZATION;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT NAVIGATION;

EID: 84910646258     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2014.06.140125     Document Type: Article

References (24)

1. Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U. S. Preventive Services Task Force. Ann Intern Med 2008;149:638-58.
2. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening test use-United States, 2012. MMWR Morb Mortal Wkly Rep 2013;62:881-8.
3. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occultblood screening for colorectal cancer. Lancet 1996;348:1472-7.
4. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
6. Myers RE, Turner B, Weinberg D, et al. Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings. Prev Med 2001;33:249-60.
7. Lurie JD, Welch HG. Diagnostic testing following fecal occult blood screening in the elderly. J Natl Cancer Inst 1999;91):1641-6.
8. Baig N, Myers RE, Turner BJ, et al. Physicianreported reasons for limited follow-up of patients with a positive fecal occult blood test screening result. Am J Gastroenterol 2003;98:2078-81.
9. Ferrat E, Le Breton J, Veerabudun K, et al. Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer 2013;109:1437-44.
10. Torring ML, Frydenberg M, Hamilton W, Hansen RP, Lautrup MD, Vedsted P. Diagnostic interval and mortality in colorectal cancer: U-shaped association demonstrated for three different datasets. J Clin Epidemiol 2012;65:669-78.
11. Thomson CS, Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer 2009;101(Suppl 2):S102-9.
12. Kravitz RL, Rolph JE, Petersen L. Omission-related malpractice claims and the limits of defensive medicine. Med Care Res Rev 1997;54:456-71.
13. Wallace E, Lowry J, Smith SM, Fahey T. The epidemiology of malpractice claims in primary care: a systematic review. BMJ Open 2013;3. pii:e002929.
14. Green BB, Wang CY, Horner K, et al. Systems of Support to Increase Colorectal Cancer Screening and Follow-up Rates (SOS): design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials 2010;31:589-603.
15. Green BB, Wang CY, Anderson ML, et al. An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: a randomized trial. Ann Intern Med 2013;158(5 Pt 1):301-11.
16. Miglioretti DL, Rutter CM, Bradford SC, et al. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization. Med Care 2008;46(9 Suppl 1):S91-6.
17. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q 1996;74:511-44.
18. Raich P, Whitley E, Thorland W, Valverde P, Faircloth D; Denver Patient Navigation Research Program. Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Cancer Epidemiol Biomarkers Prev 2012;21:1629-38.
19. Wells KJ, Lee JH, Calcano ER, et al. A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiol Biomarkers Prev 2012;21:1664-72.
20. Paskett ED, Katz ML, Post DM, et al. The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests? Cancer Epidemiol Biomarkers Prev 2012;21:1620-8.
21. Humphrey LL, Shannon J, Partin MR, O'Malley J, Chen Z, Helfand M. Improving the follow-up of positive hemoccult screening tests: an electronic intervention. J Gen Intern Med 2011;26:691-7.
22. Myers RE, Turner B, Weinberg D, et al. Impact of a physician-oriented intervention on follow-up in colorectal cancer screening. Prev Med 2004;38:375-81.
23. Singh H, Kadiyala H, Bhagwath G, et al. Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol 2009;104:942-52.
24. Heitman SJ, Ronksley PE, Hilsden RJ, Manns BJ, Rostom A, Hemmelgarn BR. Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009;7:1272-8.